+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity of human bile in cholesterol gallstone disease



Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity of human bile in cholesterol gallstone disease



Gastroenterology 114(4 Part 2): A548-A549




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144891

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(98)82230-0


Related references

Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones. European Journal of Clinical Investigation 38(9): 634-639, 2008

Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients. European Journal of Clinical Investigation 37(9): 731-736, 2007

Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels. Journal of Lipid Research 24(4): 461-468, 1983

Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients. Digestive Diseases and Sciences 24(2): 123-128, 1979

Cholesterol metabolism in human gallbladder mucosa relationship of cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment. Hepatology 16(2): 320-326, 1992

Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients. Hepatology 4(1): 107-111, 1984

Treatment of gallstone with ursodeoxycholic acid--lipid and bile acid composition in bile. Nihon Shokakibyo Gakkai Zasshi 75(8): 1196-1203, 1978

Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 99(6): 1779-1785, 1990

Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology 118(5): 912-920, 2000

Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology 89(2): 287-293, 1985

The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone. Tohoku Journal of Experimental Medicine 136(3): 235-249, 1982

Ursodeoxycholic acid reduces protein levels and their nucleation promoting activity in gallbladder bile of cholesterol stone patients. Hepatology 22(4 Part 2): 504A, 1995

Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid. Gastroenterology 87(1): 229-233, 1984

Ursodeoxycholic acid reduces mucin concentration in the gallbladder bile of patients with gallstones. Gastroenterology 108(4 Suppl. ): A1169, 1995